References
[1] Acosta-Rojas R, Becker J, Munoz-Abellana B, et al. Twin chorionicity and the risk of adverse perinatal outcome[J]. Int J Gynaecol Obstet, 2007, 96(2): 98-102.
[2] Lewi L, Jani J, Blickstein I, et al. The outcome of monochorionic diamniotic twin gestations in the era of invasive fetal therapy: a prospective cohort study[J]. Am J Obstet Gynecol, 2008, 199(5): 514.e1-514.e8.
[3] Moon-Grady AJ, Rand L, Lemley B, et al. Effect of selective fetoscopic laser photocoagulation therapy for twin-twin transfusion syndrome on pulmonary valve pathology in recipient twins[J]. Ultrasound Obstet Gynecol, 2011, 37(1): 27-33.
[4] Lopriore E, Oepkes D, Walther FJ. Neonatal morbidity in twin-twin transfusion syndrome[J]. Early Hum Dev, 2011, 87(9): 595-599.
[5] de Haseth SB, Haak MC, Roest AA, et al. Right ventricular outflow tract obstruction in monochorionic twins with selective intrauterine growth restriction[J]. Case Rep Pediatr, 2012, 2012: 426825.
[6] Lougheed J, Sinclair BG, Fung Kee Fung K, et al. Acquired right ventricular outflow tract obstruction in the recipient twin in twin-twin transfusion syndrome[J]. J Am Coll Cardiol, 2001, 38(5): 1533-1538.
[7] Quintero RA, Morales WJ, Allen MH, et al. Staging of twin-twin transfusion syndrome[J]. J Perinatol, 1999, 19(8): 550-555.
[8] Habli M, Michelfelder E, Cnota J, et al. Prevalence and progression of recipient-twin cardiomyopathy in early-stage twin-twin transfusion syndrome[J]. Ultrasound Obstet Gynecol, 2012, 39(1): 63-68.
[9] Society for Maternal-Fetal Medicine, Simpson LL. Twin-twin transfusion syndrome[J]. Am J Obstet Gynecol, 2013, 208(1): 3-18.
[10] Van Mieghem T, Done E, Gucciardo L, et al. Amniotic fluid markers of fetal cardiac dysfunction in twin-to-twin transfusion syndrome[J]. Am J Obstet Gynecol, 2010, 202(1): 48.e1-48.e7.
[11] Van Mieghem T, Lewi L, Gucciardo L, et al. The fetal heart in twin-to-twin transfusion syndrome[J]. Int J Pediatr, 2010, 2010: 379792.
[12] Rychik J, Tian Z, Bebbington M, et al. The twin-twin transfusion syndrome: spectrum of cardiovascular abnormality and development of a cardiovascular score to assess severity of disease[J]. Am J Obstet Gynecol, 2007, 197(4): 392.e1-392.e8.
[13] Crombleholme TM, Shera D, Lee H, et al. A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome[J]. Am J Obstet Gynecol, 2007, 197(4): 396.e1-396.e9.
[14] Karatza AA, Wolfenden JL, Taylor MJ, et al. Influence of twin-twin transfusion syndrome on fetal cardiovascular structure and function: prospective case-control study of 136 monochorionic twin pregnancies[J]. Heart, 2002, 88(3): 271-277.
[15] 杨森, 朱琦, 陈娇, 等. 胎儿心脏结构异常的超声诊断研究[J]. 中国当代儿科杂志, 2010, 12(2): 99-102.
[16] Van Mieghem T, Martin AM, Weber R, et al. Fetal cardiac function in recipient twins undergoing fetoscopic laser ablation of placental anastomoses for Stage IV twin-twin transfusion syndrome[J]. Ultrasound Obstet Gynecol, 2013, 42(1): 64-69.
[17] Barrea C, Debauche C, Williams O, et al. Twin-to-twin transfusion syndrome: perinatal outcome and recipient heart disease according to treatment strategy[J]. J Paediatr Child Health, 2013, 49(1): E28-E34.
[18] Stirnemann JJ, Nasr B, Proulx F, et al. Evaluation of the CHOP cardiovascular score as a prognostic predictor of outcome in twin-twin transfusion syndrome after laser coagulation of placental vessels in a prospective cohort[J]. Ultrasound Obstet Gynecol, 2010, 36(1): 52-57.